1-14 of 14
Haidong Dong
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A030: Rapid extraction and detection of extracellular vesicle-derived PD-L1 in a microfluidic platform

Ting-Wen Lo, Yuqian Zhang, Jing Liu, Yohan Kim, Haidong Dong, Fabrice Lucien, Yuguang Liu
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (21_Supplement): A030.
https://doi.org/10.1158/1557-3265.LIQBIOP24-A030
Published: 13 November 2024
View article titled, Abstract A030: Rapid extraction and detection of extracellular vesicle-derived PD-L1 in a microfluidic platform
Journal Articles

Abstract A036: Surfaceome profiling of rhabdomyosarcoma reveals B7-H3 as a mediator of immune evasion

Roxane R. Lavoie, Fabrice Lucien, Patricio C. Gargollo, Mohamed E. Ahmed, Yohan Kim, Emily Baer, Doris Phelps, Cristine M. Charlesworth, Benjamin J. Madden, Liguo Wang, Peter J. Hougthon, John Cheville, Haidong Dong, Candace F. Granberg
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (18_Supplement): A036.
https://doi.org/10.1158/1557-3265.SARCOMAS22-A036
Published: 15 September 2022
View article titled, Abstract A036: Surfaceome profiling of rhabdomyosarcoma reveals B7-H3 as a mediator of immune evasion
Journal Articles

Impact of PD-1 Blockade in Nonresponders: Pitfalls and Promise

Harry H. Yoon, Haidong Dong, Qian Shi
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (15): 3173–3175.
https://doi.org/10.1158/1078-0432.CCR-22-0932
Published: 02 August 2022
View article titled, Impact of PD-1 Blockade in Nonresponders: Pitfalls and Promise
Open the PDF for Impact of PD-1 Blockade in Nonresponders: Pitfalls and Promise in another window
Journal Articles

Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction

Mojun Zhu, Chunhua Chen, Nathan R. Foster, Christopher Hartley, Taofic Mounajjed, Marcela A. Salomao, Briant F. Fruth, Staci E. Beamer, Yohan Kim, Susan M. Harrington, Henry C. Pitot, Cristobal T. Sanhueza, Yening Feng, Joerg Herrmann, Robert R. McWilliams, Fabrice Lucien, Bing Q. Huang, Wen Wee Ma, Tanios S. Bekaii-Saab, Haidong Dong, Dennis Wigle, Daniel H. Ahn, Chris L. Hallemeier, Shanda Blackmon, Harry H. Yoon
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (14): 3021–3031.
https://doi.org/10.1158/1078-0432.CCR-22-0413
Published: 15 July 2022
View article titled, Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction
Open the PDF for Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction in another window
Includes: Supplementary data
Journal Articles

Phase II Evaluation of Stereotactic Ablative Radiotherapy (SABR) and Immunity in 11C-Choline-PET/CT–Identified Oligometastatic Castration-Resistant Prostate Cancer

Henan Zhang, Jacob J. Orme, Feven Abraha, B.J. Stish, Val J. Lowe, Fabrice Lucien, Erik J. Tryggestad, Michael S. Bold, Lance C. Pagliaro, C. Richard Choo, Debra H. Brinkmann, Matthew J. Iott, Brian J. Davis, J. Fernando Quevedo, William S. Harmsen, Brian A. Costello, Geoffrey B. Johnson, Mark A. Nathan, Kenneth R. Olivier, Thomas M. Pisansky, Eugene D. Kwon, Haidong Dong, Sean S. Park
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (23): 6376–6383.
https://doi.org/10.1158/1078-0432.CCR-21-2510
Published: 01 December 2021
View article titled, Phase II Evaluation of Stereotactic Ablative Radiotherapy (SABR) and Immunity in <sup>11</sup>C-Choline-PET/CT–Identified Oligometastatic Castration-Resistant Prostate Cancer
Open the PDF for Phase II Evaluation of Stereotactic Ablative Radiotherapy (SABR) and Immunity in <sup>11</sup>C-Choline-PET/CT–Identified Oligometastatic Castration-Resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Prevalent Homozygous Deletions of Type I Interferon and Defensin Genes in Human Cancers Associate with Immunotherapy Resistance

Zhenqing Ye, Haidong Dong, Ying Li, Tao Ma, Haojie Huang, Hon Sing Leong, Jeanette Eckel-Passow, Jean-Pierre A. Kocher, Han Liang, Liguo Wang
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (14): 3299–3308.
https://doi.org/10.1158/1078-0432.CCR-17-3008
Published: 15 July 2018
View article titled, Prevalent Homozygous Deletions of Type I Interferon and Defensin Genes in Human Cancers Associate with Immunotherapy Resistance
Open the PDF for Prevalent Homozygous Deletions of Type I Interferon and Defensin Genes in Human Cancers Associate with Immunotherapy Resistance in another window
Includes: Supplementary data
Journal Articles

Immunomodulatory Antibody Therapy of Cancer: The Closer, the Better

Roxana S. Dronca, Haidong Dong
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (5): 944–946.
https://doi.org/10.1158/1078-0432.CCR-14-2111
Published: 01 March 2015
View article titled, Immunomodulatory Antibody Therapy of Cancer: The Closer, the Better
Open the PDF for Immunomodulatory Antibody Therapy of Cancer: The Closer, the Better in another window
Journal Articles

Identification of a Soluble Form of B7-H1 That Retains Immunosuppressive Activity and Is Associated with Aggressive Renal Cell Carcinoma

Xavier Frigola, Brant A. Inman, Christine M. Lohse, Christopher J. Krco, John C. Cheville, R. Houston Thompson, Bradley Leibovich, Michael L. Blute, Haidong Dong, Eugene D. Kwon
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (7): 1915–1923.
https://doi.org/10.1158/1078-0432.CCR-10-0250
Published: 31 March 2011
View article titled, Identification of a Soluble Form of B7-H1 That Retains Immunosuppressive Activity and Is Associated with Aggressive Renal Cell Carcinoma
Open the PDF for Identification of a Soluble Form of B7-H1 That Retains Immunosuppressive Activity and Is Associated with Aggressive Renal Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

Tumor Cell and Tumor Vasculature Expression of B7-H3 Predict Survival in Clear Cell Renal Cell Carcinoma

Paul L. Crispen, Yuri Sheinin, Timothy J. Roth, Christine M. Lohse, Susan M. Kuntz, Xavier Frigola, R. Houston Thompson, Stephen A. Boorjian, Haidong Dong, Bradley C. Leibovich, Michael L. Blute, Eugene D. Kwon
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (16): 5150–5157.
https://doi.org/10.1158/1078-0432.CCR-08-0536
Published: 12 August 2008
View article titled, Tumor Cell and Tumor Vasculature Expression of B7-H3 Predict Survival in Clear Cell Renal Cell Carcinoma
Open the PDF for Tumor Cell and Tumor Vasculature Expression of B7-H3 Predict Survival in Clear Cell Renal Cell Carcinoma in another window
Journal Articles

Tumor-Infiltrating Foxp3−CD4+CD25+ T Cells Predict Poor Survival in Renal Cell Carcinoma

Sameer A. Siddiqui, Xavier Frigola, Sandra Bonne-Annee, Maria Mercader, Susan M. Kuntz, Amy E. Krambeck, Shomik Sengupta, Haidong Dong, John C. Cheville, Christine M. Lohse, Christopher J. Krco, W. Scott Webster, Bradley C. Leibovich, Michael L. Blute, Keith L. Knutson, Eugene D. Kwon
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (7): 2075–2081.
https://doi.org/10.1158/1078-0432.CCR-06-2139
Published: 02 April 2007
View article titled, Tumor-Infiltrating Foxp3<sup>−</sup>CD4<sup>+</sup>CD25<sup>+</sup> T Cells Predict Poor Survival in Renal Cell Carcinoma
Open the PDF for Tumor-Infiltrating Foxp3<sup>−</sup>CD4<sup>+</sup>CD25<sup>+</sup> T Cells Predict Poor Survival in Renal Cell Carcinoma in another window
Journal Articles

Survivin and B7-H1 Are Collaborative Predictors of Survival and Represent Potential Therapeutic Targets for Patients with Renal Cell Carcinoma

Amy E. Krambeck, Haidong Dong, R. Houston Thompson, Susan M. Kuntz, Christine M. Lohse, Bradley C. Leibovich, Michael L. Blute, Thomas J. Sebo, John C. Cheville, Alexander S. Parker, Eugene D. Kwon
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (6): 1749–1756.
https://doi.org/10.1158/1078-0432.CCR-06-2129
Published: 15 March 2007
View article titled, Survivin and B7-H1 Are Collaborative Predictors of Survival and Represent Potential Therapeutic Targets for Patients with Renal Cell Carcinoma
Open the PDF for Survivin and B7-H1 Are Collaborative Predictors of Survival and Represent Potential Therapeutic Targets for Patients with Renal Cell Carcinoma in another window
Journal Articles

PD-1 Is Expressed by Tumor-Infiltrating Immune Cells and Is Associated with Poor Outcome for Patients with Renal Cell Carcinoma

R. Houston Thompson, Haidong Dong, Christine M. Lohse, Bradley C. Leibovich, Michael L. Blute, John C. Cheville, Eugene D. Kwon
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (6): 1757–1761.
https://doi.org/10.1158/1078-0432.CCR-06-2599
Published: 15 March 2007
View article titled, PD-1 Is Expressed by Tumor-Infiltrating Immune Cells and Is Associated with Poor Outcome for Patients with Renal Cell Carcinoma
Open the PDF for PD-1 Is Expressed by Tumor-Infiltrating Immune Cells and Is Associated with Poor Outcome for Patients with Renal Cell Carcinoma in another window
Journal Articles

Implications of B7-H1 Expression in Clear Cell Carcinoma of the Kidney for Prognostication and Therapy

R. Houston Thompson, Haidong Dong, Eugene D. Kwon
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (2): 709s–715s.
https://doi.org/10.1158/1078-0432.CCR-06-1868
Published: 25 January 2007
View article titled, Implications of B7-H1 Expression in Clear Cell Carcinoma of the Kidney for Prognostication and Therapy
Open the PDF for Implications of B7-H1 Expression in Clear Cell Carcinoma of the Kidney for Prognostication and Therapy in another window
Journal Articles

Expression of Functional B7-H2 and B7.2 Costimulatory Molecules and Their Prognostic Implications in De novo Acute Myeloid Leukemia

Hideto Tamura, Kazuo Dan, Koji Tamada, Kyoko Nakamura, Yumiko Shioi, Hideya Hyodo, Sheng-Dian Wang, Haidong Dong, Lieping Chen, Kiyoyuki Ogata
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (16): 5708–5717.
https://doi.org/10.1158/1078-0432.CCR-04-2672
Published: 22 August 2005
View article titled, Expression of Functional B7-H2 and B7.2 Costimulatory Molecules and Their Prognostic Implications in <em>De novo</em> Acute Myeloid Leukemia
Open the PDF for Expression of Functional B7-H2 and B7.2 Costimulatory Molecules and Their Prognostic Implications in <em>De novo</em> Acute Myeloid Leukemia in another window